Antimalarial 3-arylamino-6-benzylamino-1,2,4,5-tetrazines

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 15, 2010, Pages 4496-4498

  Nhu, Duong ^a   Duffy, Sandra ^b   Avery, Vicky M ^b   Hughes, Andrew ^c   Baell, Jonathan B ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

Malaria; Plasmodium falciparum; Tetrazines

Indexed keywords

ANTIMALARIAL AGENT; TETRAZINE DERIVATIVE; UNCLASSIFIED DRUG; WEHI 0033352; WEHI 0059743;

ANIMAL EXPERIMENT; ANTIMALARIAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; LEISHMANIA INFANTUM; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI;

ANTIMALARIALS; BENZYLAMINES; PLASMODIUM FALCIPARUM; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAZOLES;

PLASMODIUM FALCIPARUM;

EID: 77955412820     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.06.036     Document Type: Article

References (18)

1. R.W. Snow, C.A. Guerra, A.M. Noor, H.Y. Myint, and S.I. Hay Nature 434 2005 214
2. J.L. Gallup, and J.D. Sachs Am. J. Trop. Med. Hyg. 64 2001 85
3. K. Haldar, D.A. Milner, S.C. Murphy Jr., and T.E. Taylor Annu. Rev. Pathol.: Mech. Dis. 2 2007 217
4. B.M. Greenwood, K. Bojang, C.J.M. Whitty, and G.A.T. Targett Lancet 365 2005 1487
5. M. Frederich, J.-M. Dogne, L. Angenot, and P.D. Mol Curr. Med. Chem. 9 2002 1435
6. L.H. Miller, D.I. Baruch, K. Marsh, and O.K. Doumbo Nature 415 2002 673
7. M.F. Good Trends Parasitol. 21 2005 29
8. R.L. Brady, and A. Cameon Curr. Drug Target 5 2004 137
9. U. D'Alessandro Expert Opin. Pharmacother. 10 2009 1291
10. H. Hisaeda, K. Yasutomo, and K. Himeno Int. J. Biochem. Cell Biol. 37 2005 700
11. F. Cosledan, L. Fraisse, A. Pellet, F. Guillou, B. Mordmuller, P.G. Kremsner, A. Moreno, D. Mazier, J.-P. Maffrand, and B. Meunier Proc. Natl. Acad. Sci. U.S.A. 105 2008 17579
12. M.D.P. Crespo, T.D. Avery, E. Hassen, E. Fox, T.V. Robinson, P. Valente, D.K. Taylor, and L. Tilley Antimicrob. Agents Chemother. 52 2008 98
13. This was undertaken at the Swiss Tropical Research Institute. Compounds 1 and 2 belonged to primary screening hit sets derived from screening our high throughput screening library against Trypanosoma brucei-derived farnesyl pyrophosphate synthase (FPPS) and Trypanosoma cruzi-derived trypanothione reductase, respectively. The potent and selective antimalarial activity of compounds 1 and 2 was therefore serendipitous and may have arisen via mechanisms unrelated to the enzyme targets for the initial screen. We have recently disclosed the results of the trypanothione reductase high throughput screen (Ref. 17).
14. L.M. Werbel, D.J. McNamara, N.L. Colbry, J.L. Johnson, M.J. Degnan, and B. Whitney J. Heterocycl. Chem. 16 1979 881
15. G.L. Rusinov, N.I. Latosh, I.I. Ganebnykh, R.I. Ishmetova, N.K. Ignatenko, and O.N. Chupakhin Russ. J. Org. Chem. 42 2006 757
16. J.X. Kelly, M.J. Smilkstein, R. Brun, S. Wittlin, R.A. Cooper, K.D. Lane, A. Janowsky, R.A. Johnson, R.A. Dodean, R. Winter, D.J. Hinrichs, and M.K. Riscoe Nature 459 2009 270
17. G.A. Holloway, J.B. Baell, A.H. Fairlamb, P.M. Novello, J.P. Parisot, J. Richardson, K.G. Watson, and I.P. Street Bioorg. Med. Chem. Lett. 17 2007 1422
18. G.A. Holloway, W.N. Charman, A.H. Fairlamb, R. Brun, M. Kaiser, E. Kostewicz, P.M. Novello, J.P. Parisot, J. Richardson, I.P. Street, K.G. Watson, and J.B. Baell Antimicrob. Agents Chemother. 53 2009 2824